0001209191-22-033336.txt : 20220601
0001209191-22-033336.hdr.sgml : 20220601
20220601213238
ACCESSION NUMBER: 0001209191-22-033336
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220531
FILED AS OF DATE: 20220601
DATE AS OF CHANGE: 20220601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TRUEX PAUL F
CENTRAL INDEX KEY: 0001120362
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38899
FILM NUMBER: 22989125
MAIL ADDRESS:
STREET 1: PENINSULA PHARMACEUTICALS, INC.
STREET 2: 1751 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Milestone Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001408443
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
BUSINESS PHONE: (514) 336-0444
MAIL ADDRESS:
STREET 1: 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-31
0
0001408443
Milestone Pharmaceuticals Inc.
MIST
0001120362
TRUEX PAUL F
C/O MILESTONE PHARMACEUTICALS INC.
1111 DR. FREDERIK-PHILIPS BLVD, STE 420
MONTR?AL
A8
H4M 2X6
QUEBEC, CANADA
1
0
0
0
Common Shares
2022-05-31
4
M
0
8016
1.12
A
8016
D
Common Shares
2022-05-31
4
M
0
45072
1.54
A
53088
D
Common Shares
2022-05-31
4
M
0
22870
1.54
A
75958
D
Common Shares
2022-05-31
4
M
0
822
2.66
A
76780
D
Common Shares
2022-05-31
4
P
0
5000
5.60
A
81780
D
Stock Option (right to buy)
1.12
2022-05-31
4
M
0
8016
0.00
D
2025-08-26
Common Shares
8016
0
D
Stock Option (right to buy)
1.54
2022-05-31
4
M
0
45072
0.00
D
2027-07-21
Common Shares
45072
0
D
Stock Option (right to buy)
1.54
2022-05-31
4
M
0
22870
0.00
D
2028-10-15
Common Shares
22870
2659
D
Stock Option (right to buy)
2.66
2022-05-31
4
M
0
822
0.00
D
2028-11-20
Common Shares
822
117
D
Fully vested and exercisable.
Twenty-five percent (25%) of the shares subject to the option shall vest on October 15, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Twenty-five percent (25%) of the shares subject to the option shall vest on November 21, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
/s/ Jason Minio, Attorney-in-Fact
2022-06-01